Cell Theraputics Market

Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell Theraputics Market contains market size and forecasts of Cell Theraputics in Global, including the following market information:
Global Cell Theraputics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Theraputics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Theraputics include Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc. and Lineage Cell Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Theraputics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Theraputics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Theraputics Market Segment Percentages, by Type, 2021 (%)

• Stem Cells
• Immunocyte

Global Cell Theraputics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell Theraputics Market Segment Percentages, by Application, 2021 (%)

• Allogeneic Cell Therapy
• Autologous Cell Therapy
• Xenogeneic Cell Therapy

Global Cell Theraputics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell Theraputics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Cell Theraputics revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Cell Theraputics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb Company (Celgene)
• Bluebird Bio
• Crispr Therapeutics
• Roche (Spark Therapeutics)
• PTC Therapeutics
• Moderna Therapeutics
• Quanterix
• Brainstorm Cell Therapeutics Inc.
• Lineage Cell Therapeutics
• Cti Biopharma
• Atara Biotherapeutics, Inc
• Adaptimmune